SCHEMBL16503753

SCHEMBL16503753

Cc1cc(Cl)cc(C(=O)NC(C)(C)C)c1NC(=O)c1cnc(Cn2nnc(C(F)(F)F)n2)nc1-c1ccccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPAS1 Q99814 1/20 0.41
▸ NPC1 O15118 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ PDE4B Q07343 2/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ PDE3B Q13370 1/20 0.36
▸ PDE11A Q9HCR9 1/20 0.36
▸ DGAT2 Q96PD7 3/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ ALOX5AP P20292 1/20 0.34
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ NTRK1 P04629 5/20 0.33
▸ PTGER1 P34995 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1696948 0.93 EPAS1 (0.42) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503749 0.92 EPAS1 (0.37) EPAS1NPC1HPGDRAB9AL3MBTL1
SCHEMBL16503738 0.91 EPAS1 (0.44) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503748 0.91 EPAS1 (0.41) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503751 0.85 EPAS1 (0.38) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503762 0.84 HPGD (0.39) EPAS1NPC1HPGDRAB9AL3MBTL1
SCHEMBL16503752 0.83 SLC2A1 (0.41) EPAS1
SCHEMBL16503763 0.83 EPAS1 (0.37) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503742 0.81 HPGD (0.39) NPC1HPGDRAB9AL3MBTL1DGAT2
SCHEMBL16503735 0.81 NPC1 (0.37) EPAS1NPC1HPGDRAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8980886-B2 Anthranilic acid derivatives BAYER CROPSCIENCE AG (DE) 2015-03-17 — — US disclosed
US-20110312953-A1 ANTHRANILIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2011-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312953-A1 ANTHRANILIC ACID DERIVATIVES ANTXR2, NQO2, ACLY EPAS1 3339/4885NPC1 4635/4885HPGD 2834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback